Australia's Provectus Algae closes Series A Extension as breakthrough programmes move toward commercial scale

November 18, 2026 | Wednesday | News

$4.3 million extension brings total Series A funding to more than $14 million

Provectus Algae, the Australian biotechnology startup using advanced biomanufacturing to develop next-generation biological products, has closed a $4.3 million extension to its Series A financing, bringing total Series A funding to more than $14 million.

The Series A was led by At One Ventures, with the extension welcoming Queensland Investment Corporation (QIC) as a new investor, including through the Queensland Government’s A$30 million Sowing the Seeds of Farming Innovation Fund, managed by QIC, alongside continued support from existing shareholders.

The additional investment follows a period of significant technical and commercial progress for Provectus Algae, with programmes developed through its Precision Photosynthesis® and AI-enabled discovery and biomanufacturing platform advancing from development toward commercialisation.

Leading that transition is Surf’N’Turf®, Provectus Algae’s methane-reducing cattle feed technology, which is now being commercialised through Proteus Ag.

 

The company is simultaneously advancing programmes in human nutraceuticals and crop-protection biologics, creating additional commercial pathways from the same underlying discovery and biomanufacturing platform.

Its proprietary Precision Photosynthesis® technology combines controlled biological systems with AI-enabled discovery and biomanufacturing capabilities.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account